Prokinetic effects of diatrizoate meglumine (Gastrografin (R)) in a zebrafish for opioid-induced constipation model
- Kim, Dongwoo; Koun, Soonil; Kim, Seung Young; Ha, Young Ran; Choe, Jung Wan; Jung, Sung Woo; Hyun, Jong Jin; Jung, Young Kul; Koo, Ja Seol; Yim, Hyung Joon; Lee, Sang Woo
- Issue Date
- Zebrafish; constipation; gastrografin
- Animal Cells and Systems, v.25, no.5, pp.264 - 271
- Journal Title
- Animal Cells and Systems
- Start Page
- End Page
- Constipation is a common disease that reduces life quality. Drugs of various mechanisms are being developed to resolve this affliction. Intestinal motility can be easily monitored in zebrafish, and so we selected this organism to develop a constipation model to measure drug-induced prokinetic effects. In this study, intestinal motility was monitored in zebrafish by tracking intestinal transit using fluorescence, after which an opioid-induced constipation model was established using loperamide. We then evaluated the prokinetic effect of diatrizoate meglumine (Gastrografin (R)), which has been empirically used to treat post-operative ileus or adhesive small bowel obstructions. Diatrizoate meglumine was effective in promoting bowel movements in an opioid-induced zebrafish constipation model and its prokinetic effect was associated with an increased expression of interstitial cells of Cajal (ICC) markers. Therefore, the loperamide-induced zebrafish constipation model developed herein is a promising tool to evaluate novel constipation therapies.
- Files in This Item
- There are no files associated with this item.
- Appears in
- 4. Research institute > Zebrafish Translational Medical Research Center > 1. Journal Articles
- 2. Clinical Science > Department of Gastroenterology and Hepatology > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.